Page 131 - Read Online

Page 12 of 13 Zahrai et al. Vessel Plus 2023;7:32 https://dx.doi.org/10.20517/2574-1209.2023.100

infarction. The primary angioplasty in myocardial infarction study group. N Engl J Med 1993;328:673-9. DOI
28. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy
Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial
infarction. N Engl J Med 1997;336:1621-8. DOI
29. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical
outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute
coronary syndromes (GUSTO-IIb) trial. Circulation 1999;100:14-20. DOI
30. Byrne RA, Rossello X, Coughlan JJ, et al; ESC Scientific Document Group. 2023 ESC guidelines for the management of acute
coronary syndromes. Eur Heart J 2023;44:3720-826. DOI PubMed
31. Bernard C, Morgant MC, Jazayeri A, et al. Optimal timing of coronary artery bypass grafting in haemodynamically stable patients
after myocardial infarction. Biomedicines 2023;11:979. DOI PubMed PMC
32. Biancari F, Onorati F, Rubino AS, et al. Outcome of emergency coronary artery bypass grafting. J Cardiothorac Vasc Anesth
2015;29:275-82. DOI
33. Chen HL, Liu K. Timing of coronary artery bypass graft surgery for acute myocardial infarction patients: a meta-analysis. Int J
Cardiol 2014;177:53-6. DOI PubMed
34. Lang Q, Qin C, Meng W. Appropriate timing of coronary artery bypass graft surgery for acute myocardial infarction patients: a meta-
analysis. Front Cardiovasc Med 2022;9:794925. DOI PubMed PMC
35. Maganti M, Brister SJ, Yau TM, Collins S, Badiwala M, Rao V. Changing trends in emergency coronary bypass surgery. J Thorac
Cardiovasc Surg 2011;142:816-22. DOI PubMed
36. Klempfner R, Barac YD, Younis A, et al. Early referral to coronary artery bypass grafting following acute coronary syndrome, trends
and outcomes from the acute coronary syndrome israeli survey (ACSIS) 2000-2010. Heart Lung Circ 2018;27:175-82. DOI
37. Lemaire A, Vagaonescu T, Ikegami H, Volk L, Verghis N, Lee LY. Delay in coronary artery bypass grafting for STEMI patients
improves hospital morbidity and mortality. J Cardiothorac Surg 2020;15:86. DOI PubMed PMC
38. Liakopoulos OJ, Slottosch I, Wendt D, et al. Surgical revascularization for acute coronary syndromes: a report from the North Rhine-
Westphalia surgical myocardial infarction registry. Eur J Cardiothorac Surg 2020;58:1137-44. DOI
39. Thielmann M, Neuhäuser M, Marr A, et al. Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial
infarction. Ann Thorac Surg 2007;84:17-24. DOI
40. Bianco V, Kilic A, Gleason TG, et al. Timing of coronary artery bypass grafting after acute myocardial infarction may not influence
mortality and readmissions. J Thorac Cardiovasc Surg 2021;161:2056-64.e4. DOI
41. Sintek CF, Pfeffer TA, Khonsari S. Surgical revascularization after acute myocardial infarction. J Thorac Cardiovasc Surg
1994;107:1317-22. DOI PubMed
42. Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG
without extracorporeal circulation. Chest 1998;113:1290-5. DOI PubMed
43. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave
acute myocardial infarction. Circulation 1997;96:778-84. DOI
44. Pietilä K, Harmoinen A, Pöyhönen L, Ruosteenoja R. C-reactive protein in subendocardial and transmural myocardial infarcts. Clin
Chem 1986;32:1596-7. DOI PubMed
45. Parikh SV, de Lemos JA, Jessen ME, et al; CRUSADE and ACTION Registry-GWTG Participants. Timing of in-hospital coronary
artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National cardiovascular data
registry ACTION registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines).
JACC Cardiovasc Interv 2010;3:419-27. DOI PubMed
46. Kite TA, Kurmani SA, Bountziouka V, et al. Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-
analysis of randomized controlled trials. Eur Heart J 2022;43:3148-61. DOI PubMed PMC
47. Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among
patients with ST-elevation myocardial infarction. JAMA 2014;312:2019-27. DOI
48. Steg PG, James SK, Atar D, et al; Task Force on the management of ST-segment elevation acute myocardial infarction of the
European society of cardiology (ESC). ESC guidelines for the management of acute myocardial infarction in patients presenting with
ST-segment elevation. Eur Heart J 2012;33:2569-619. DOI PubMed
49. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention
for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary
intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol
2016;67:1235-50. DOI PubMed
50. De Innocentiis C, Zimarino M, De Caterina R. Is complete revascularisation mandated for all patients with multivessel coronary
artery disease? Interv Cardiol 2018;13:45-50. DOI PubMed PMC
51. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2015;10:1024-
94. DOI
52. Vlaar PJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for
multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J
Am Coll Cardiol 2011;58:692-703. DOI